Tirzepatida causa estreñimiento
Summary: Constipation is one of the most common side effects of tirzepatide, reported in up to 17% of participants in SURMOUNT-1 at the 15 mg dose, driven by delayed gastric emptying plus reduced food and fluid intake.
This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.
Yes. Tirzepatide causes constipation, and it is one of the most frequently reported side effects in every major trial of the drug. In SURMOUNT-1, the phase 3 obesity trial that supported Zepbound's FDA approval, constipation was reported in 17% of participants on the 15 mg dose, compared with 9% on placebo [1]. The FDA Zepbound label lists constipation as a common adverse reaction at every dose strength [2]. So if you started tirzepatide and your bowel rhythm fell apart, that is the drug, not your imagination.
The good news: most cases are mild, dose-dependent, and respond to a few cheap interventions before they ever require a prescription.
How common is it, really
The numbers depend on which trial you read and which indication you use the drug for. The pattern is consistent.
| Trial / source | Dose | Constipation rate |
|---|---|---|
| SURMOUNT-1 (obesity, NEJM 2022) | 15 mg | 17% (vs 9% placebo) |
| SURMOUNT-1 (obesity, NEJM 2022) | 10 mg | 17% |
| SURMOUNT-1 (obesity, NEJM 2022) | 5 mg | 12% |
| SURPASS T2D trials (Mounjaro label) | 15 mg | 7% |
| SURPASS T2D trials (Mounjaro label) | 5 to 10 mg | 6% |
The higher rate in SURMOUNT-1 compared with the diabetes trials is the eye-catching part. Two things explain it. First, the obesity dosing schedule pushes patients to higher doses (10 and 15 mg) more often than the diabetes protocol does. Second, the obesity cohort is, by trial design, eating less. Food volume drops, fiber drops with it, and the colon has less material to move. The mechanism amplifies itself.
Why tirzepatide constipates you
Three things happen at once when you inject tirzepatide weekly, and all three push toward constipation.
Delayed gastric emptying. Tirzepatide activates both GLP-1 and GIP receptors. Both slow how fast the stomach hands food off to the small intestine. Estimates from gastric emptying studies put the slowdown at 30 to 50% at therapeutic doses. The whole transit chain backs up behind it. Stool spends more time in the colon, the colon absorbs more water, and what comes out is harder and drier.
Reduced food and fiber intake. The point of the drug is appetite suppression. People on tirzepatide eat 20 to 30% fewer calories. They also eat less fiber, because fiber lives in foods (whole grains, beans, bulky vegetables, fruit) that you eat less of when you are not hungry. Lower fiber means lower stool bulk, and lower stool bulk means slower, harder evacuation.
Dehydration. GI side effects of tirzepatide include nausea and reduced thirst signaling. Patients drink less. Combine reduced fluid intake with reduced food volume and slowed transit, and the colon dehydrates the stool further than it normally would.
None of these mechanisms are exotic. They are the reason every GLP-1 and dual incretin drug shares the same GI side effect profile, including the gut feeling of "I have not been in five days and I do not know why."
How long it lasts
Most people see constipation peak in the first four to eight weeks after starting a new dose, then settle as the gut adapts to that dose. Then they titrate up to the next dose strength and the cycle restarts. The titration steps (2.5, 5, 7.5, 10, 12.5, 15 mg) exist for exactly this reason: the gut needs time to acclimate at each level.
Constipation that lasts more than two weeks at a stable dose, or that gets worse rather than better with dose stability, is no longer the expected adaptation curve. That is when prevention shifts to active treatment.
Prevention: do these from day one
If you wait until you are constipated to start managing constipation, you are already losing. The interventions below take a few days to work. Start them the day you fill your first tirzepatide prescription, not the day your colon stops cooperating.
Hydration: 2 liters minimum
The Academy of Nutrition and Dietetics recommends 9 to 13 cups of fluid per day for healthy adults. On tirzepatide, drift toward the high end. Two liters (about 8 cups) is the floor, not the goal. Water, sparkling water, herbal tea, broth, sugar-free electrolyte mixes all count. Coffee counts net positive on hydration despite the diuretic effect, but it is not a substitute for plain water.
A practical trick: fill a 1 liter bottle in the morning, drink it by lunch, refill, drink it by dinner. If the bottle is still half full at noon, you are not on pace.
Fiber: 25 to 35 grams daily, weighted toward soluble
Soluble fiber (oats, beans, lentils, apples, psyllium, chia seeds) absorbs water and forms a gel that softens stool. Insoluble fiber (wheat bran, leafy vegetables, nuts) adds bulk but can worsen bloating in the early weeks of a GLP-1. If you are picking one to prioritize, go soluble.
Most US adults eat 10 to 15 grams of fiber per day. Doubling that on tirzepatide requires intent. A bowl of oatmeal with chia seeds and berries hits 12 grams before lunch. A cup of black beans at dinner adds another 15. That is the day done.
Increase fiber gradually over a week or two. Going from 12 grams to 35 grams overnight produces gas and cramping that you will blame on the drug.
Magnesium: 300 to 400 mg at night
Magnesium citrate or magnesium oxide pulls water into the bowel and softens stool. It is cheap, available everywhere, and well tolerated. A 400 mg dose at bedtime is a common protocol. If you get loose stools, drop to 200 mg. If nothing happens after a week, the issue is probably not magnesium-responsive.
People with kidney disease should not self-treat with magnesium. Talk to a prescriber first.
Movement: 20 to 30 minutes daily
Walking, cycling, yoga, swimming, gardening. The mode does not matter. The act of moving the body mechanically stimulates colonic motility through the gastrocolic reflex and through abdominal muscle activation. The US guidelines call for 150 minutes of moderate activity per week. Most people on tirzepatide who get reliable bowel movements walk after meals.
Treatment: when prevention is not enough
If you are doing all of the above and still not having a comfortable bowel movement at least three times a week, escalate.
First line: psyllium husk (Metamucil and equivalents)
A teaspoon of psyllium in a full glass of water, once or twice daily, adds bulk and soft texture to stool. Most people see results within two to three days. Take it at least two hours apart from oral medications because the gel can interfere with absorption.
Second line: polyethylene glycol (MiraLAX, Movicol)
Polyethylene glycol 3350 is the laxative the American College of Gastroenterology specifically endorses for GLP-1 related constipation [4]. It works osmotically, pulling water into the bowel without cramping, and it has the best safety profile for ongoing use of any OTC laxative. Standard dose is 17 grams (one capful) dissolved in 8 ounces of water daily. Results in 12 to 72 hours.
Other OTC options
- Docusate sodium (Colace). A stool softener, 100 mg twice daily. Mild. Works better as prevention than as rescue.
- Senna (Senokot). A stimulant laxative. Effective fast, but not for daily long-term use because the colon can become dependent on it.
- Bisacodyl (Dulcolax). Stronger stimulant. Reserve for rescue, not maintenance.
- Magnesium citrate liquid. A full bottle clears the bowel within hours. Aggressive. Use for genuine rescue.
| Option | Onset | Use for |
|---|---|---|
| Psyllium husk | 1 to 3 days | Daily maintenance |
| Polyethylene glycol (MiraLAX) | 12 to 72 hours | Daily or as needed |
| Magnesium 300 to 400 mg | 6 to 12 hours | Daily prevention |
| Docusate sodium | 1 to 3 days | Daily maintenance |
| Senna | 6 to 12 hours | Occasional rescue |
| Magnesium citrate (full bottle) | 30 min to 6 hours | Emergency rescue |
When it is time for a prescription
If two weeks of consistent OTC management does nothing, your prescriber has options. Linaclotide (Linzess), plecanatide (Trulance), and prucalopride (Motegrity) all treat chronic idiopathic constipation through different mechanisms (intestinal secretagogues for the first two, a 5-HT4 agonist for the third). They are not first line for GLP-1 constipation, but they are well studied and effective when the standard tools fail.
A small subset of patients cannot tolerate tirzepatide's GI burden at any dose. For them, the answer is often dose reduction (back to 2.5 or 5 mg) or a switch to a different agent. Talk to your prescriber before unilaterally cutting your dose, but know that the option exists.
Red flags: when constipation becomes an emergency
Most tirzepatide constipation is uncomfortable, not dangerous. A small number of cases progress to something worse. The FDA Zepbound and Mounjaro labels both warn about acute gastrointestinal disease, including ileus (bowel paralysis) and intestinal obstruction [2][3]. Postmarketing case reports describe both.
Call your prescriber or go to urgent care if you have:
- Severe abdominal pain that does not ease, especially crampy waves of pain or a constant deep ache.
- Abdominal distention (your belly visibly bigger and tight).
- Vomiting, especially if it smells feculent or you cannot keep liquids down.
- No bowel movement and no gas passed for more than 72 hours. Gas stopping is a louder warning than stool stopping.
- Fever combined with any of the above.
Those are obstruction or ileus signs. Do not wait them out. Do not double up on stimulant laxatives in the hope of forcing things through; stimulant laxatives can worsen a true obstruction.
What about diarrhea? Both can happen.
Tirzepatide causes diarrhea in roughly 19% of participants at the 15 mg dose in SURMOUNT-1, more often than it causes constipation [1]. Some people swing between the two, especially in the first month of a new dose. The same gut motility changes that slow stool transit in one person speed it up in another, often based on baseline gut habits and what they are eating that week. If you are dealing with both, manage the dominant symptom first and let the secondary one settle.
Frequently asked questions
- How long does tirzepatide constipation last?
- Usually one to four weeks at each new dose, then it eases as the gut adapts. If it persists more than two weeks at a stable dose, start active treatment with psyllium or polyethylene glycol.
- Is constipation worse at higher doses of tirzepatide?
- Yes. In SURMOUNT-1, constipation rates rose from 12% at 5 mg to 17% at 10 and 15 mg. The dose-response is the reason titration starts at 2.5 mg.
- Can I take MiraLAX every day on tirzepatide?
- Yes. Polyethylene glycol 3350 is the laxative most gastroenterologists recommend for ongoing GLP-1 related constipation. It is safe for daily use, non-habit-forming, and works osmotically.
- Does tirzepatide slow gastric emptying permanently?
- No. The effect wears off within days to weeks of stopping the drug. Gut motility returns to baseline. The slowdown is reversible.
- Will tirzepatide cause gallstones?
- Rapid weight loss from any cause raises gallstone risk, and tirzepatide is no exception. The FDA Zepbound label notes cholecystitis as a postmarketing adverse event. Severe right upper abdominal pain warrants imaging.
- Can tirzepatide cause hemorrhoids?
- Indirectly. Hard stool and straining from tirzepatide-related constipation can trigger or worsen hemorrhoids. Treat the underlying constipation and the hemorrhoids usually settle.
- What is the best fiber supplement for tirzepatide constipation?
- Psyllium husk (Metamucil, generic equivalents). Soluble, well tolerated, and proven in clinical trials of constipation. One teaspoon in a full glass of water, once or twice daily.
- Does tirzepatide cause hypoglycemia on its own?
- Not typically as monotherapy in non-diabetic users. Risk rises sharply when combined with insulin or sulfonylureas. Dose adjustment of those medications is usually required.
- Can I prevent constipation before it starts?
- Yes, and you should. Start hydration (2 liters daily), fiber (25 to 35 grams, mostly soluble), and a magnesium supplement on day one of your first injection. Do not wait for symptoms.
- When should I call my doctor about tirzepatide constipation?
- Severe abdominal pain, abdominal distention, vomiting, fever, or no bowel movement and no gas for more than 72 hours. Those signal possible obstruction or ileus and require urgent evaluation.
The bottom line
Constipation on tirzepatide is common, predictable, and almost always manageable. Hydrate aggressively, eat more soluble fiber than feels necessary, take magnesium at night, walk after meals, and keep polyethylene glycol on standby. If two weeks of disciplined management does not move things, escalate to a prescription option through your provider rather than just stacking stimulant laxatives.
The rare cases that turn dangerous announce themselves clearly: severe pain, distention, vomiting, no gas passing. Treat those as the emergencies they are. Everything else is a tractable side effect of a drug that, for most patients, is doing exactly what it was prescribed to do [5].
References
- Jastreboff AM et al, Tirzepatide once weekly for treatment of obesity, NEJM 2022 (SURMOUNT-1)
- FDA Zepbound (tirzepatide) prescribing information
- FDA Mounjaro (tirzepatide) prescribing information
- American College of Gastroenterology clinical guideline on chronic idiopathic constipation
- Medical News Today, Tips for managing constipation with Mounjaro